Connecticut Health Center COVID-19 Survey Summary Report

Latest data from December 30, 2021

Number of Health Center respondents = 16 (100% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 13,752
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 79.40%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 4,001
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 85.53%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 17.61% 12.70%
White, Hispanic/Latino Patients 17.76% 17.45%
Black/African American, Non-Hispanic/Latino Patients 20.53% 24.39%
Black/African American, Hispanic/Latino Patients 2.49% 1.70%
Asian Patients3 1.51% 1.35%
American Indian/Alaska Native Patients3 0.39% 0.50%
Native Hawaiian/Other Pacific Islander Patients3 0.75% 1.60%
Patients with More than one race3 2.55% 2.72%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 21.92% 25.32%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 4.85% 4.27%
Unreported/Refused to Report Race and Ethnicity 9.64% 8.00%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 3,110
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 84.25%
COVID-19 Immunization Series Completed 2,364
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 84.62%
COVID-19 Immunization Series Additional 9,409
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 72.50%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 12.06% 11.84% 21.21%
White, Hispanic/Latino Patients 17.91% 18.36% 15.66%
Black/African American, Non-Hispanic/Latino Patients 12.73% 11.80% 10.38%
Black/African American, Hispanic/Latino Patients 1.96% 1.40% 1.33%
Asian Patients3 3.02% 3.09% 4.49%
American Indian/Alaska Native Patients3 0.48% 0.34% 0.55%
Native Hawaiian/Other Pacific Islander Patients3 0.39% 0.42% 0.26%
Patients with More than one race3 1.22% 1.69% 0.97%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 26.78% 28.09% 22.30%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 12.09% 10.11% 8.52%
Unreported/Refused to Report Race and Ethnicity 11.35% 12.86% 14.34%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 0.00%
1 to 24 Hours 12.50%
More Than 24 Hours 81.25%
N/A 6.25%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 6.25%
Staffing to administer the vaccine 62.50%
Vaccine confidence 18.75%
Vaccine storage capacity 0.00%
Vaccine supply 12.50%
Other 6.25%
None 18.75%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 6.25%
Average Percent of Health Center Visits Conducted Virtually 34.06%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 43.75%
Number of Mobile Van Sites 5
Number of Pop-up Clinics 66
Number of School-Based Vaccination Sites 13
Number of Family Vaccination Clinics 65

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 68.75%
None 31.25%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 6.25%
Patient awareness/education 0.00%
Staffing capacity 12.50%
Therapy administration/onsite logistics 25.00%
Other 0.00%
None 68.75%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 3
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 11,350

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 100.00%
Provide to General Public Who Came to the Health Center 66.67%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 33.33%
Provide at Other Community Events 33.33%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 66.67%
Other 33.33%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

Date Last Reviewed:  January 2022